• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    FILE - The Aug. 12, 2005 file photo shows the logo of Swiss company Novartis in Basel, Switzerland. Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday, April 22, 2014 with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.  (AP Photo/Keystone, Steffen Schmidt)
    Business

    New drug sales help boost Novartis Q1 profit

    John Heilprin -
    April 24, 2014 4:46 pm
    0
    When things go well, the Food and Drug Administration typically hears little praise from Congress and the media. (Thinkstock)
    Healthcare

    Manhattan Moment: Seeking best practices at the FDA

    Paul Howard -
    April 24, 2014 4:00 am
    0
    Valeant, Ackman make $45.6B Allergan bid
    Business

    Valeant, Ackman make $45.6B Allergan bid

    Washington Examiner -
    April 23, 2014 12:40 am
    0
    State issues restrictions for painkiller Zohydro
    Business

    State issues restrictions for painkiller Zohydro

    Philip Marcelo -
    April 22, 2014 10:56 pm
    0
    Drug firm exec gets 16 months in inside-trade case
    Business

    Drug firm exec gets 16 months in inside-trade case

    Washington Examiner -
    April 22, 2014 8:58 pm
    0
    FDA panel rejects combination pain pill
    Business

    FDA panel rejects combination pain pill

    Washington Examiner -
    April 22, 2014 6:55 pm
    0
    FILE - The Oct. 19, 2012 file photo shows a Novartis employee in a laboratory of Novartis in Prangins near Nyon, Switzerland. Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday, April 22, 2014 with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.  (AP Photo/Keystone, Yannick Bailly)
    Business

    Novartis reshapes business with GSK, Lilly deals

    John Heilprin -
    April 22, 2014 6:04 pm
    0
    Botox maker Allergan draws bid from Valeant
    Business

    Botox maker Allergan draws bid from Valeant

    KEN SWEETMATTHEW PERRONE -
    April 22, 2014 4:03 am
    0
    Valeant to bid for Botox maker Allergan
    Business

    Valeant to bid for Botox maker Allergan

    KEN SWEETMATTHEW PERRONE -
    April 22, 2014 12:08 am
    0
    Gov. Patrick: Appeal of Zohydro ruling unlikely
    Business

    Gov. Patrick: Appeal of Zohydro ruling unlikely

    Washington Examiner -
    April 16, 2014 9:39 pm
    0
    1...147148149...153Page 148 of 153
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter